Par Pharma Suit Tests FDA's Drug Pricing Pushback
Efforts by the U.S. Food and Drug Administration to combat dramatic price spikes for prescription drugs are being tested by a new Par Pharmaceutical lawsuit accusing regulators of improperly letting compounding...To view the full article, register now.
Already a subscriber? Click here to view full article